Selenium and sulindac are synergistic to inhibit intestinal tumorigenesis in Apc/p21 mice

BACKGROUND: Both selenium and non-steroidal anti-inflammatory drug (NSAID) sulindac are effective in cancer prevention, but their effects are affected by several factors including epigenetic alterations and gene expression. The current study was designed to determine the effects of the combination o...

Descripción completa

Detalles Bibliográficos
Autores principales: Bi, Xiuli, Pohl, Nicole, Dong, Huali, Yang, Wancai
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2013
Materias:
Short Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3566909/
https://www.ncbi.nlm.nih.gov/pubmed/23327547
http://dx.doi.org/10.1186/1756-8722-6-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3566909/
https://www.ncbi.nlm.nih.gov/pubmed/23327547
http://dx.doi.org/10.1186/1756-8722-6-8

Ejemplares similares